| Date | Time | Source | Headline | Symbol | Company |
| 06/10/2005 | 8:15PM | PR Newswire (US) | Long-Term Data on BYETTA(TM) Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People with Type | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/10/2005 | 6:30PM | PR Newswire (US) | Study Shows BYETTA(TM) Improves Blood Sugar Levels as Effectively as Insulin Glargine | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2005 | 5:43PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/09/2005 | 9:00AM | PR Newswire (US) | Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/06/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Presentation of 12 Abstracts at the American Diabetes Association Annual Meeting | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 06/03/2005 | 8:30AM | PR Newswire (US) | Amylin Presents Results From Pramlintide Obesity Program at 14th Annual European Congress on Obesity | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/20/2005 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Annual Meeting of Stockholders and Presentation | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/13/2005 | 5:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Banc of America Securities' Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/04/2005 | 10:43AM | PR Newswire (US) | MORNING UPDATE: Man Securities Inc. Issues Alerts for SYMC, AMLN, NXTP, APOL, and KOSP | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/04/2005 | 8:30AM | PR Newswire (US) | Amylin Pharmaceuticals Reports First Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 05/02/2005 | 11:14AM | PR Newswire (US) | MORNING UPDATE: Mankus-Lavelle Group Issues Alerts for MWD, AMLN, HLTH, HIG, and CAH | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/29/2005 | 6:42PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast First Quarter Results and Morgan Stanley Global Healthcare Unplugged Conference Presentation | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 04/29/2005 | 8:30AM | PR Newswire (US) | Amylin and Lilly Announce FDA Approval of BYETTA(TM) (Exenatide) Injection | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/25/2005 | 4:30PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Smith Barney Citigroup Healthcare Conference and Lehman Brothers Global Healthcare Conferen | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/16/2005 | 4:59PM | PR Newswire (US) | Amylin Pharmaceuticals Announces FDA Approval of SYMLIN(R) for Insulin-Using Type 2 and Type 1 Diabetes | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 03/02/2005 | 6:00AM | PR Newswire (US) | Amylin Pharmaceuticals Reports 2004 Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/24/2005 | 7:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Year-End Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 02/07/2005 | 7:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/27/2005 | 6:00AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Exercise of Over-Allotment Option by Underwriters | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/21/2005 | 4:15PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at Piper Jaffray Health Care Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/21/2005 | 6:00AM | PR Newswire (US) | Amylin Pharmaceuticals Announces Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/18/2005 | 6:00AM | PR Newswire (US) | Amylin Pharmaceuticals Files Preliminary Prospectus Supplement for Public Offering of Common Stock | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 01/05/2005 | 7:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/05/2004 | 11:00PM | PR Newswire (US) | Amylin Pharmaceuticals Provides Update On Clinical Development Programs | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 12/01/2004 | 9:01PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Corporate Update | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2004 | 7:30AM | PR Newswire (US) | Exenatide LAR Data Support Initiation of Phase 2 Multi-Dose Study in 2005 | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 11/02/2004 | 7:15AM | PR Newswire (US) | Amylin Pharmaceuticals Reports Third Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/26/2004 | 5:30PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Third Quarter Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/22/2004 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals to Present at UBS Global Life Sciences Conference | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/20/2004 | 8:15AM | PR Newswire (US) | Amylin Pharmaceuticals Submits Complete Response to FDA for SYMLIN(R) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |